Risultati di ricerca
Morgan Cheatham is a Vice President at Bessemer Venture Partners, a global venture capital firm with over $9 billion in assets under management, where he focuses on investments in healthcare and life sciences from early to growth stages.
20 dic 2022 · 2023. Performance of ChatGPT on USMLE: potential for AI-assisted medical education using large language models. PLOS Digit Health. 2023; 2 (2): e0000198. TH Kung, M Cheatham, A Medenilla, C...
29 giu 2024 · By age 21, he had created two new degree programs at Brown, in Neuroeconomics and in LGBTQ+ Health, that both continue to operate today. Five years later, he's a vice president at Bessemer...
Morgan Cheatham is a vice president in the New York City office where he focuses on investments in healthcare and life sciences from early to growth stages. He has a particular interest in companies leveraging unique datasets and computational methods to improve patient care from bench to bedside.
Investing with Bessemer Venture Partners where I focus on healthcare and life sciences…. · Experience: Decoding Bio · Education: The Warren Alpert Medical School of Brown University ...
- 500+
- Bessemer Venture Partners
- 23K
- New York, New York, United States
I’m a member of the Editorial Team at New England Journal of Medicine AI and am pursuing medical training at Brown Medical School with a focus on bioinformatics research. Subscribe. I write to learn in public. On this blog, I tackle a wide range of topics in healthcare, life sciences, AI, startups, and venture capital.
Morgan Cheatham's 3 research works with 405 citations and 2,210 reads, including: Evaluation of GPT-3.5 and GPT-4 for supporting real-world information needs in healthcare delivery
